You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 104 No. 1, JULY 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Acquired Hemolytic Anemia in Chronic Lymphocytic Leukemia and the Lymphomas

Survival and Response to Therapy in Twenty-Seven Cases

ROBERT A. KYLE, M.D.; JOSEPH M. KIELY, M.D.; J. M. STICKNEY, M.D.

AMA Arch Intern Med. 1959;104(1):61-67.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The presence of severe anemia in patients with chronic lymphocytic leukemia or malignant lymphoma is regarded ordinarily as a bad prognostic sign, often indicating advanced disease or extensive involvement of bone marrow. In some patients, however, marked anemia is due to an overt hemolytic process, and recognition of this fact will lead to proper therapy and a more favorable prognosis.

In 1906, Pappenheim 1 stated that the anemia in lymphocytic leukemia was chiefly myelophthisic in nature but that it was possible in some instances for the anemia to be of hemolytic origin and caused by toxic hemolyzing substances from the tumor tissue. The first report of acquired hemolytic anemia associated with chronic lymphocytic leukemia was given by Paschkis,2 in 1927. That same year Holler and Paschkis 3 presented the first report of Hodgkin's disease complicated by acquired hemolytic anemia. Since then other cases of Hodgkin's disease, lymphosarcoma, and chronic . . . [Full Text PDF of this Article]


Author Affiliations

Rochester, Minn.

Fellow in Medicine, Mayo Foundation (Dr. Kyle) and Section of Medicine (Dr. Kiely and Dr. Stickney), Mayo Clinic and Mayo Foundation. The Mayo Foundation, Rochester, Minn., is a part of the Graduate School of the University of Minnesota.


Footnotes

Submitted for publication Oct. 9, 1958.

Abridgment of thesis submitted by Dr. Kyle to the Faculty of the Graduate School of the University of Minnesota in partial fulfillment of the requirements for the degree of Master of Science in Medicine.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.